Omgyno

OMGYNO - a female-led femtech platform that targets the needs of women in conservative and low-resourced communities - is redesigning the sexual and reproductive health (SRH) experience with human-centered design, progressive values, and technology. Active as a for-profit in Greece since 2021 and as a hybrid company in Lebanon since 2023, OMGYNO is bridging the gender health gap by empowering users with self-guided access to both new digital and health tech. OMGYNO’s platform offers: (1) traceable on-demand and anonymous at-home sexual health testing in partnership with local diagnostics laboratories; (2) telemedicine support with vetted local healthcare professionals; (3) SRH awareness raising through digital campaigns, and (4) a femshop that sells sustainable menstrual health products. As an EU-based company, we are fully GDPR compliant. As such, we also help build MENA’s SRH evidence base through (anonymized) data analyses & strategic partnerships. Despite our primary focus on service delivery, we are committed to strengthening SRH research throughout the region - a topic which is historically under researched and under-resourced. Within the first year of operations in Lebanon, 33% of OMGYNO HPV DNA home tests came back positive for high-risk strains, 73% of which indicated co-infection with more than one oncogenic HPV type. Moreover, 20% of those who tested positive for a high-risk strain had never tested before.